Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology
Editor Note: For more information about this release, please scroll to bottom.
LONDON, March 19, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Tuesday, March 18, 2014, with the NASDAQ Composite closing at 4,333.31, up 1.25%, the Dow Jones Industrial Average ending the session at 16,336.19, up 0.55% and the S&P 500 edging 0.72% higher to finish the trading session at 1,872.25. During the session, gains in the Information Technology, Health Care, and Energy sectors positively impacted the broader market. A number of stocks saw large movements, including Synta Pharmaceuticals Corp. (NASDAQ: SNTA), BG Medicine Inc. (NASDAQ: BGMD), Abraxas Petroleum Corp. (NASDAQ: AXAS), and xG Technology Inc. (NASDAQ: XGTI). Free technical research on SNTA, BGMD, AXAS and XGTI can be downloaded upon signing up at:
http://www.investor-edge.com/318-register
Shares in Synta Pharmaceuticals Corp. edged 8.28% higher, finishing Tuesday's session at $4.71. The stock fluctuated between $4.34 and $4.76 during the session with a trading volume of 3.39 million shares as compared to a three months average volume of 2.42 million shares. Shares in Synta Pharmaceuticals Corp. have gained 8.03% in the previous three trading sessions and 8.53% in the last three months, while the same has fallen by 10.11% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.17% during the trading session and charted up 1.47% in the last one month. Furthermore, the stock is trading at the RSI of 31.08 and below its 50-day and 200-day moving averages of $5.84 and $5.58, respectively. Sign up today to read free research on SNTA at:
http://www.investor-edge.com/318-SNTA-19Mar2014.pdf
BG Medicine Inc.'s stock closed Tuesday's session at $1.85, which is 31.21% higher than the previous day's closing price of $1.41. A total of 9.30 million shares were traded as compared to a three months average volume of 1.51 million shares. The stock oscillated between $1.46 and $1.87 during the trading session. BG Medicine Inc.'s shares have surged 42.31% in the previous three trading sessions, 43.97% in the last one month and 77.88% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.17% during the trading session and charted up 8.57% in the previous three months. Moreover, the stock is trading at the RSI of 59.46 and above its 50-day and 200-day moving averages of $1.29 and $1.06, respectively. Sign up today to read free research on BGMD at:
http://www.investor-edge.com/318-BGMD-19Mar2014.pdf
On Tuesday, shares in Abraxas Petroleum Corp. ended the session at $3.91, up 6.79%, hitting a new 52-week high of $3.96. A total of 3.41 million shares were traded as compared to a three months average volume of 1.00 million shares. During the session, the stock traded between $3.70 and $3.96. The company's shares have advanced 19.16% in the last one month and 21.76% in the previous three months. Abraxas Petroleum Corp.'s shares traded at a PE ratio of 17.70 and have gone up 19.85% on YTD basis. The S&P 500 Energy Sector Index mapped a gain of 0.78% during the trading session and charted up 1.40% in the last one month. Further, the stock is trading at the RSI of 66.99 and above its 50-day and 200-day moving averages of $3.25 and $2.89, respectively. Sign up today to read free research on AXAS at:
http://www.investor-edge.com/318-AXAS-19Mar2014.pdf
xG Technology Inc.'s stock finished Tuesday's session at $3.46, recording a 28.62% gain. A total of 6.08 million shares were traded which is above the three months average volume of 0.96 million shares. The stock vacillated between $2.63 and $3.85 during the session. xG Technology Inc.'s shares have rallied 160.15% in the last one month and 118.99% on YTD basis. The S&P 500 Telecommunication Services Sector Index mapped a gain of 0.66% during the trading session and charted up 1.21% in the last one month. Additionally, the stock is trading at the RSI of 54.28 and above its 50-day moving average of $1.90. Sign up today to read free research on XGTI at:
http://www.investor-edge.com/318-XGTI-19Mar2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article